Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP study
暂无分享，去创建一个
E. Zeggini | N. W. Rayner | G. Dedoussis | E. Marouli | L. Southam | S. Hackinger | B. Prins | K. Lamnissou | K. Kuchenbaecker | Eleni Zengini | Vasiliki Mamakou | Ioannis Serafetinidis | A. Thanopoulou | F. Gonidakis | N. Tentolouris | V. Kontaxakis | Eirini Glezou | E. Tsompanaki | Athina Karabela